JP Fermand

790 total citations
16 papers, 615 citations indexed

About

JP Fermand is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, JP Fermand has authored 16 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 9 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in JP Fermand's work include Multiple Myeloma Research and Treatments (10 papers), Cancer Treatment and Pharmacology (5 papers) and Cancer therapeutics and mechanisms (3 papers). JP Fermand is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), Cancer Treatment and Pharmacology (5 papers) and Cancer therapeutics and mechanisms (3 papers). JP Fermand collaborates with scholars based in France, Switzerland and United States. JP Fermand's co-authors include J C Brouet, M Benbunan, Jean Soulier, Philippe Ravaud, J Gerota, Sylvie Castaigné, M Séligmann, J M Cosset, Yves Lévy and Sylvie Chevret and has published in prestigious journals such as Blood, The American Journal of Medicine and Journal of Bone and Mineral Research.

In The Last Decade

JP Fermand

16 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JP Fermand France 9 506 288 283 117 55 16 615
JM Hernández Spain 8 346 0.7× 115 0.4× 187 0.7× 100 0.9× 51 0.9× 12 426
TE Witzig United States 8 334 0.7× 212 0.7× 261 0.9× 105 0.9× 58 1.1× 8 451
N Belli Italy 7 461 0.9× 248 0.9× 100 0.4× 93 0.8× 106 1.9× 11 568
Philippe Dessauw France 5 429 0.8× 411 1.4× 144 0.5× 68 0.6× 24 0.4× 7 523
J. Treleaven United Kingdom 10 354 0.7× 214 0.7× 177 0.6× 135 1.2× 77 1.4× 17 636
Prapti A. Patel United States 13 323 0.6× 156 0.5× 240 0.8× 91 0.8× 61 1.1× 60 532
Nuria Quintana Spain 6 446 0.9× 276 1.0× 382 1.3× 163 1.4× 131 2.4× 7 646
Axelle Daviet France 9 523 1.0× 185 0.6× 411 1.5× 240 2.1× 29 0.5× 10 651
Philip R. Greipp United States 7 201 0.4× 117 0.4× 163 0.6× 85 0.7× 25 0.5× 8 324
MJ Pébusque France 12 534 1.1× 127 0.4× 243 0.9× 205 1.8× 241 4.4× 19 810

Countries citing papers authored by JP Fermand

Since Specialization
Citations

This map shows the geographic impact of JP Fermand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JP Fermand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JP Fermand more than expected).

Fields of papers citing papers by JP Fermand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JP Fermand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JP Fermand. The network helps show where JP Fermand may publish in the future.

Co-authorship network of co-authors of JP Fermand

This figure shows the co-authorship network connecting the top 25 collaborators of JP Fermand. A scholar is included among the top collaborators of JP Fermand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JP Fermand. JP Fermand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Roos‐Weil, Damien, Philippe Moreau, Hervé Avet‐Loiseau, et al.. (2011). Impact of genetic abnormalities after allogeneic stem cell transplantation in multiple myeloma: a report of the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire. Haematologica. 96(10). 1504–1511. 37 indexed citations
2.
Avet‐Loiseau, Hervé, Jean Soulier, JP Fermand, et al.. (2010). Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasone. Leukemia. 24(3). 623–628. 102 indexed citations
3.
Arnulf, Bertrand, Arnaud Jaccard, Didier Bouscary, et al.. (2009). A448 Intermittent Dex/Thal as Pretransplantation and Maintenance Treatment in De Novo MM: A Randomized Trial. Clinical Lymphoma & Myeloma. 9. S71–S72. 2 indexed citations
4.
Arnulf, Bertrand, Séverine Lecourt, Jean Soulier, et al.. (2006). Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma. Leukemia. 21(1). 158–163. 154 indexed citations
5.
Roux, Sophie, C. Bergot, JP Fermand, et al.. (2003). Evaluation of Bone Mineral Density and Fat-Lean Distribution in Patients With Multiple Myeloma in Sustained Remission. Journal of Bone and Mineral Research. 18(2). 231–236. 11 indexed citations
6.
Lévy, Vincent, Raphaël Porcher, V. Leblond, et al.. (2001). Evaluating treatment strategies in advanced Waldenström macroglobulinemia: use of quality-adjusted survival analysis. Leukemia. 15(9). 1466–1470. 15 indexed citations
7.
Pertuiset, Édouard, et al.. (1997). Localisations neuroméningées du myélome multiple: trois observations et revue de la littérature. La Revue de Médecine Interne. 18(8). 646–651. 12 indexed citations
8.
Fermand, JP, Sylvie Chevret, Philippe Ravaud, et al.. (1993). High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients. Blood. 82(7). 2005–2009. 6 indexed citations
9.
Fermand, JP, Sylvie Chevret, Philippe Ravaud, et al.. (1993). High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients. Blood. 82(7). 2005–2009. 103 indexed citations
10.
Trédaniel, Jean, Pauline Brice, Éric Lepage, et al.. (1992). The significance of a residual mediastinal mass following treatment for aggressive non-Hodgkin's lymphomas. European Respiratory Journal. 5(2). 170–173. 6 indexed citations
11.
Mariette, Xavier, Philippe Ravaud, J Frija, et al.. (1992). Bone densitometry in patients with multiple myeloma. The American Journal of Medicine. 93(6). 595–598. 27 indexed citations
12.
Lepage, Éric, M F D'Agay, Pauline Brice, et al.. (1992). Hodgkin's disease, clinical stages I, II A-B and IIIA. Results of brief chemotherapy followed by irradiation.. PubMed. 34(3). 247–55. 2 indexed citations
13.
Fermand, JP, J Gerota, M Benbunan, et al.. (1989). Treatment of aggressive multiple myeloma by high-dose chemotherapy and total body irradiation followed by blood stem cells autologous graft. Blood. 73(1). 20–23. 4 indexed citations
14.
Fermand, JP, Yves Lévy, J Gerota, et al.. (1989). Treatment of aggressive multiple myeloma by high-dose chemotherapy and total body irradiation followed by blood stem cells autologous graft. Blood. 73(1). 20–23. 123 indexed citations
15.
Fermand, JP, et al.. (1985). Associated chronic lymphocytic leukemia and multiple myeloma: origin from a single clone. Blood. 66(2). 291–293. 3 indexed citations
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by JM Hernández Breakdown of academic impact, for papers by TE Witzig Breakdown of academic impact, for papers by N Belli Breakdown of academic impact, for papers by Philippe Dessauw Breakdown of academic impact, for papers by J. Treleaven Breakdown of academic impact, for papers by Prapti A. Patel Breakdown of academic impact, for papers by Nuria Quintana Breakdown of academic impact, for papers by Axelle Daviet Breakdown of academic impact, for papers by Philip R. Greipp Breakdown of academic impact, for papers by MJ Pébusque
Rankless by CCL
2026